| Filed On | Filing |
|---|---|
| 21 Oct 2026 |
Form 4: Capers Julien E., See Remarks
Received 787,300 shares as a grant or award |
| 07 Oct 2026 |
Form 4: Jones Mitchell Lawrence, See Remarks
Received 2,620,850 shares by exercise or conversion · Gave up 1,031,102 shares to cover exercise price or tax ($1.54M) |
| 07 Oct 2026 |
Form 4: Finley John David, Director
Received 3,227,384 shares by exercise or conversion · Gave up 1,411,982 shares to cover exercise price or tax ($2.1M) |
| 05 Oct 2026 |
Form 4: Williams Donald Allen, Director
Bought 10,000 shares ($14.2K) · Bought 10,000 shares ($14.6K) |
| 21 Aug 2026 |
Form 4: Finley John David, Director
Gave 88,400 shares as a gift · Acquired 88,400 shares (Gift) |
| 10 Jul 2026 |
Form 4: Baltera Robert Jr., Director
Bought 20,000 shares ($39.8K) · Bought 25,000 shares ($48.9K) |
| 08 Jul 2026 |
Form 4: Baltera Robert Jr., Director
Bought 20,000 shares ($41K) · Bought 30,000 shares ($61K) |
| 08 Jul 2026 |
Form 4: Jones Mitchell Lawrence, Chief Medical Officer
Received 131,167 shares by exercise or conversion · Sold 51,880 shares ($107K) |
| 08 Jul 2026 |
Form 4: Finley John David, Director
Received 335,167 shares by exercise or conversion · Sold 146,798 shares ($303K) · Received 133 shares by exercise or conversion ($93.1) |
| 06 Jul 2026 |
Form 4: Baltera Robert Jr., Director
Bought 20,000 shares ($39.6K) · Bought 10,000 shares ($19.8K) |
| 18 Jun 2026 |
Form 4: Baltera Robert Jr., Director
Received 336,904 shares as a grant or award |
| 12 Jun 2026 |
Form 4: Wei Binxian, Director
Received 592,300 shares as a grant or award · Received 20,200 shares by exercise or conversion |
| 12 Jun 2026 |
Form 4: Williams Donald Allen, Director
Received 1,498,900 shares as a grant or award · Received 60,666 shares by exercise or conversion |
| 12 Jun 2026 |
Form 4: Chuang Emil, Director
Received 592,300 shares as a grant or award · Received 20,200 shares by exercise or conversion |
| 12 Jun 2026 |
Form 4: Zwick Jordan Michael, Director
Received 336,904 shares as a grant or award |
| 13 Feb 2026 |
Form 4: Jones Mitchell Lawrence, Chief Medical Officer
Received 8,000 shares by exercise or conversion · Sold 1,989 shares ($3.48K) |
| 13 Feb 2026 |
Form 4: Finley John David, Director
Received 13,333 shares by exercise or conversion · Sold 3,896 shares ($6.82K) |
| 11 Feb 2026 |
Form 4: Jones Mitchell Lawrence, Chief Medical Officer
Granted 787,000 Restricted Stock Units |
| 11 Feb 2026 |
Form 4: Finley John David, Director
Granted 2,011,000 Restricted Stock Units |
| 21 Jan 2026 |
Form 4: Williams Donald Allen, Director
Bought 5,000 shares ($8.36K) |
Loading...